AHG:NSD-Akso Health Group ADR (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 1.11

Change

-0.11 (-9.02)%

Market Cap

USD 0.13B

Volume

3.09K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

N/A

USD 9.40B
PDCO Patterson Companies Inc

N/A

USD 2.31B
ZYXI Zynex Inc

N/A

USD 0.36B
EDAP EDAP TMS SA

N/A

USD 0.27B
YI 111 Inc

N/A

USD 0.09B
COSM Cosmos Health Inc.

N/A

USD 0.01B

ETFs Containing AHG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.00% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.00% 100% F 90% A-
Trailing 12 Months  
Capital Gain 208.33% 100% F 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 208.33% 100% F 97% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 15.34% 71% C- 77% C+
Dividend Return 15.34% 57% F 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 95.95% 29% F 16% F
Risk Adjusted Return 15.98% 43% F 55% F
Market Capitalization 0.13B 43% F 42% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector